Filing metadata

Accession number
0000950170-24-032262
Form type
Form 4
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Mar 15, 2024
Reporting period
Mar 13, 2024
Description
Insider transaction

Explore SEC Filings Hub